In‑vitro diagnostic test and digital platform for hospitals and laboratories that measures true GFR by quantifying serum iohexol via UHPLC‑UV and returns results within hours. Provides high‑accuracy GFR for physicians in nephrology, oncology, transplantation and ICU to detect renal disease and optimize treatment while keeping component cost low.